Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Tablets, Oral, Dose escalation to a MTD from a starting dose of 850 mg/m², twice a day (BID) x 14d per cycle, until disease progression

IV, Dose escalation to a MTD from a starting dose of 40 mg/m², Q3wks, until disease progression

IV, Dose Escalation to a MTD from a starting dose of 32 mg/m², Q3wks, until disease progression

IV, Dose escalation to an MTD from a starting dose of 60 mg/m², Q3wks, Until disease progression

IV, Dose escalation to an MTD from a starting dose of Paclitaxel 135 mg/m², Q3wks, Until disease progression

Tablets, Oral, Dose escalation to a MTD from a starting dose of 400 mg, daily (QD), until disease progression